These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 795205)

  • 41. [Clinical testing of the preparations SPN 40150 and N 150].
    Lietz W
    Z Allgemeinmed; 1973 Aug; 49(24):1135-6. PubMed ID: 4271794
    [No Abstract]   [Full Text] [Related]  

  • 42. [Intraoperative measurement of peripheral resistance in arterial circulatory disturbances and the effect of acetylcholine and nicotinic acid].
    Heinrich P; Förster HJ
    Z Exp Chir; 1971; 4(3):148-51. PubMed ID: 5162948
    [No Abstract]   [Full Text] [Related]  

  • 43. [Controlled study on the effect of a new substance in peripheral arterial diseases].
    Poti R; Megha A; Pini M; Bulletti G
    Minerva Cardioangiol; 1974; 22(7-8):574-87. PubMed ID: 4605589
    [No Abstract]   [Full Text] [Related]  

  • 44. [Vasoactive drugs in peripheral arterial perfusion disorders. Problems, principles and results of the determination of therapeutic efficacy].
    Heidrich H
    Dtsch Med Wochenschr; 1985 Aug; 110(31-32):1219-24. PubMed ID: 3926447
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hepagrisevit forte in chronic liver diseases].
    Kollatz E; Kramer A; Schopper W; Siede W
    Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151
    [No Abstract]   [Full Text] [Related]  

  • 46. [Evaluation of a drug combination for antihypertensive therapy in general practice].
    Voigt U
    Med Welt; 1981 Sep; 32(37):1368-74. PubMed ID: 7029196
    [No Abstract]   [Full Text] [Related]  

  • 47. [The management of hyperlipoproteinemia with Liproreduct].
    Fenster R
    Ther Ggw; 1974 May; 113(5):813-24. PubMed ID: 4603893
    [No Abstract]   [Full Text] [Related]  

  • 48. [Comparative study of various schedules of buflomedil treatment in peripheral arterial insufficiency of the lower limbs. Evaluation of its therapeutic efficacy].
    Paoletti V; Mammarella A; Alessandrini A; Barlattani M
    Clin Ter; 1984 Jul; 110(1):29-36. PubMed ID: 6237843
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of a combination of vasoactive substances on metabolism and the rheoencephalogram].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Klin Wochenschr; 1973 Sep; 123(37):533-8. PubMed ID: 4148002
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pharmacological and therapeutic effects of nicotinic acid unrelated to the vitamin activity].
    Condorelli L
    Acta Vitaminol Enzymol; 1977; 31(1-5):57-84. PubMed ID: 580690
    [No Abstract]   [Full Text] [Related]  

  • 51. [Comparison of 2 effective doses of Fludilat in peripheral vascular disorders in a double-blind trial].
    König FK
    Med Welt; 1973 Sep; 24(39):1490-2. PubMed ID: 4588974
    [No Abstract]   [Full Text] [Related]  

  • 52. [Lipid-lowering effect of a combination of clofibrate and DL-alpha-tocopherol nicotinate in unselected hyperlipemic patients].
    Gniwotta E; Herter B
    ZFA (Stuttgart); 1977 Apr; 53(10):565-8. PubMed ID: 324162
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy of chronic cerebrovascular insufficiency. Controlled comparative study of 2 cerebral antihypoxidosis agents].
    Szobor A; Klein M; Bräuer H
    MMW Munch Med Wochenschr; 1982 Oct; 124(41):897-900. PubMed ID: 6815511
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prostaglandins including prostacyclin in the treatment of peripheral arterial occlusive disorders].
    Alexander K
    Internist (Berl); 1989 Jul; 30(7):429-39. PubMed ID: 2670810
    [No Abstract]   [Full Text] [Related]  

  • 55. Vasodilator drugs in peripheral vascular disease.
    Coffman JD
    J Maine Med Assoc; 1975 Oct; 66(10):262-9. PubMed ID: 1104731
    [No Abstract]   [Full Text] [Related]  

  • 56. Reaction of transcutaneous PO2 and laser Doppler flow signal on intraarterial infusion of PGE1 and nucleotide phosphates in patients with peripheral arterial occlusive disease.
    Caspary L; Creutzig A; Alexander K
    Vasa Suppl; 1987; 17():17-22. PubMed ID: 3470960
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravenous prostavasin--therapy in peripheral arterial occlusive disease in Fontaine's stages III and IV. Early and late results of a screening study.
    Heidrich H; Meuche C; Ranft J; Rummel S; Peters A
    Prog Clin Biol Res; 1989; 301():411-6. PubMed ID: 2678131
    [No Abstract]   [Full Text] [Related]  

  • 58. [Action of nitrates on pressure and volume in the peripheral circulation of patients with coronary heart disease and with peripheral arterial occlusive diseases].
    Caesar K; Niemeyer H; Hossmann V; Saborowski F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1738-41. PubMed ID: 347799
    [No Abstract]   [Full Text] [Related]  

  • 59. [Resignation--a problem of advanced age? Treatment of psychogenic and somatogenic geriatric complaints].
    Ofenstein C
    Z Allgemeinmed; 1975 May; 51(15):721-3. PubMed ID: 1096481
    [No Abstract]   [Full Text] [Related]  

  • 60. [Intravenous infusions in the treatment of arterial occlusive diseases from the surgical point of view].
    Hugeneck J
    Wien Med Wochenschr; 1976 Sep; 126(38):542-4. PubMed ID: 788353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.